Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)
China flag China · Delayed Price · Currency is CNY
7.42
-0.82 (-9.95%)
Apr 25, 2025, 2:45 PM CST

SHE:002581 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Market Capitalization
5,4367,0209,63210,39114,08512,093
Upgrade
Market Cap Growth
-27.12%-27.12%-7.30%-26.23%16.48%153.18%
Upgrade
Enterprise Value
5,1226,7069,53610,51514,11712,037
Upgrade
Last Close Price
8.2410.6414.6015.7521.3518.33
Upgrade
PE Ratio
----51.98-
Upgrade
PS Ratio
15.0819.4822.4129.1034.9843.68
Upgrade
PB Ratio
2.473.184.434.195.705.52
Upgrade
P/TBV Ratio
2.733.534.914.606.256.13
Upgrade
P/OCF Ratio
-----653.31
Upgrade
EV/Sales Ratio
14.2118.6122.1929.4535.0543.48
Upgrade
EV/EBITDA Ratio
211.97-----
Upgrade
EV/FCF Ratio
-329.18-----
Upgrade
Debt / Equity Ratio
000.010.070.070.08
Upgrade
Asset Turnover
--0.170.130.160.09
Upgrade
Inventory Turnover
--1.131.061.270.80
Upgrade
Quick Ratio
--3.021.051.833.17
Upgrade
Current Ratio
--3.721.422.203.70
Upgrade
Return on Equity (ROE)
-6.52%-6.52%-13.84%-0.03%11.96%-8.65%
Upgrade
Return on Assets (ROA)
---3.74%-3.90%-4.90%-5.55%
Upgrade
Return on Capital (ROIC)
-2.28%-2.28%-4.03%-4.15%-5.09%-5.75%
Upgrade
Earnings Yield
-2.53%-1.96%-3.45%-0.14%1.92%-1.62%
Upgrade
FCF Yield
-0.29%-0.22%-0.42%-0.83%-0.76%-0.41%
Upgrade
Payout Ratio
----2.48%-
Upgrade
Buyback Yield / Dilution
-0.01%-0.01%-0.22%0.21%0.00%-0.02%
Upgrade
Total Shareholder Return
-0.01%-0.01%-0.22%0.21%0.00%-0.02%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.